May, 29 2025 Thursday 02:47 Hrs
  • SENSEX :   81,312.32

  • Top commodity trading and broking companies in India-239.31( -0.29%) 28-May-2025
top-arrow-market
Sensex 81312.32 -239.31  (-0.29) 28-May-2025
Previous Day Close
81551.63
Today's High/Low
High Low
  •  
  •  
81613.36 81244.02

Company News Details

Alivus Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543322
INE03Q201024
229.7492749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALIVUS
27.32
13265.41
EPS(TTM)
Face Value()
Div & Yield %
39.6
2
0.46
 

Alivus Life Sciences Ltd
Alivus Life Sciences standalone net profit rises 44.85% in the March 2025 quarter
May 16,2025
Net profit of Alivus Life Sciences rose 44.85% to Rs 141.87 crore in the quarter ended March 2025 as against Rs 97.94 crore during the previous quarter ended March 2024. Sales rose 21.05% to Rs 649.55 crore in the quarter ended March 2025 as against Rs 536.60 crore during the previous quarter ended March 2024.

For the full year,net profit rose 3.13% to Rs 485.63 crore in the year ended March 2025 as against Rs 470.89 crore during the previous year ended March 2024. Sales rose 4.54% to Rs 2386.88 crore in the year ended March 2025 as against Rs 2283.21 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales649.55536.60 21 2386.882283.21 5
OPM %30.5526.36 -28.6029.53 -
PBDT207.27144.21 44 714.74684.74 4
PBT191.30129.68 48 654.13631.29 4
NP141.8797.94 45 485.63470.89 3
Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.